Hailong Zhang

Company: Blueray Biopharma

Job title: Chief Executive Officer

Seminars:

Novel E3 Ligase-Based Targeted Protein Degradation: Potential Applications Within & Beyond Cancer Therapy 11:30 am

Somatic mutation of some E3 ligases create novel E3 ligase that are not exist in normal tissues Targeted protein degradation using the mutated E3 ligases are very specific and only happen with the presence of the mutated E3 ligase Novel E3-based TPD and potential applications are discussed with an exampleRead more

day: Bootcamp Day